Quest diagnostics awarded cdc contracts for h5 avian influenza and oropouche virus test development

Quest to develop laboratory tests and support public health reporting and laboratory readiness for cdc's preparedness strategy; company to introduce clinical testing for avian flu later this month based on one of the awards secaucus, n.j. , oct. 23, 2024 /prnewswire/ -- quest diagnostics (nyse: dgx), a leading provider of diagnostic information services, today announced that it has been awarded several contracts by the u.s. centers for disease control and prevention (cdc) to support testing and sustained laboratory readiness for two emerging infectious diseases recently identified in people in the americas.
DGX Ratings Summary
DGX Quant Ranking